These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26656176)

  • 1. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma.
    Chen L; Jia J; Zang Y; Li J; Wan B
    Neoplasma; 2019 Jul; 66(4):507-515. PubMed ID: 30868890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
    Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X
    Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.
    Xiao X; Zhou L; Cao P; Gong H; Zhang Y
    Int J Oncol; 2015 Jan; 46(1):161-74. PubMed ID: 25309979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA XIST increases the aggressiveness of laryngeal squamous cell carcinoma by regulating miR-124-3p/EZH2.
    Xiao D; Cui X; Wang X
    Exp Cell Res; 2019 Aug; 381(2):172-178. PubMed ID: 31071316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
    Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
    Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.
    Tian L; Zhang J; Ge J; Xiao H; Lu J; Fu S; Liu M; Sun Y
    Med Oncol; 2014 Jan; 31(1):785. PubMed ID: 24297308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
    Zhang D; Ni Z; Xu X; Xiao J
    Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
    Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal lncRNA LINC02191 Promotes Laryngeal Squamous cell Carcinoma Progression by Targeting miR-204-5p/RAB22A Axis and Regulating PI3K/Akt/mTOR Pathway.
    Kang Z; Zhang C; Huangfu H
    Biochem Genet; 2024 Jun; 62(3):2117-2133. PubMed ID: 37863866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
    Liu F; He Y; Shu R; Wang S
    Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
    Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
    Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
    [No Abstract]   [Full Text] [Related]  

  • 17. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
    Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
    Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.
    Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L
    Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.